LOGIN
Injection with Autologous Blood or Dextrose for Lateral Epicondylitis
April 2025
Injection with Autologous Blood or Dextrose for Lateral Epicondylitis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
In the Treatment of Lateral Epicondylitis by Percutaneous Perforation, Injectables Have No Added Value.
Clin Orthop Relat Res. 2024 Feb 1;482(2):325-336.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred sixty-six patients with lateral epicondylitis were randomized to receive autologous blood injection (n=54), dextrose injection (n=57), or percutaneous perforation alone (n=55). The primary outcome was VAS pain score during provocation at 5 months. Secondary outcomes included VAS scores at rest, during activity, and after maximum grip strength; Oxford Elbow Score (OES); QuickDASH; PRTEE...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.